Video Experimental Relacionado
Updated: Jul 10, 2026
09:16
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
Published on: October 30, 2016
Mutantes negativos dominantes de una subunidad de toxina: un enfoque para la terapia del ántrax
B R Sellman1, M Mourez, R J Collier
1Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA.
Science (New York, N.Y.)
|April 28, 2001
Resumen
Los científicos desarrollaron mutantes dominantes negativos del antígeno protector que bloquean la entrada de la toxina del ántrax en las células. Estos mutantes son prometedores para el desarrollo de nuevas terapias de ántrax mediante la inhibición de la acción de la toxina.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Microbiología Microbiología.
- Toxicología Toxicología.
Sus antecedentes:
- El antígeno protector (AP) de la toxina del ántrax facilita la entrada de la toxina en las células del huésped.
- El PA se heptameriza e inserta en las membranas celulares para translocar los componentes tóxicos.
Objetivo del estudio:
- Para identificar mutantes dominantes negativos del antígeno protector.
- Para evaluar el potencial terapéutico de estos mutantes contra la toxina del ántrax.
Principales métodos:
- Co-ensamblaje de mutantes PA dominantes negativos con PA de tipo salvaje.
- Evaluación de la inhibición de la translocación en cultivos celulares.
- Evaluación en un modelo de intoxicación animal.
Principales resultados:
- Se han identificado mutantes PA dominantes negativos que se co-ensamblan con PA de tipo silvestre.
- Estos mutantes bloquearon efectivamente la capacidad de translocación por membrana de la PA.
- Inhibición significativa de la acción de la toxina del ántrax observada in vitro e in vivo.
Conclusiones:
- Los mutantes PA dominantes negativos pueden inhibir la toxina del ántrax.
- Estos mutantes representan una estrategia terapéutica potencial para el tratamiento del ántrax.
Más Videos Relacionados
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
Videos de Conceptos Relacionados
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:26Curing Methods
Concrete members with a small surface-to-volume ratio are cured by oiling and moistening the forms before casting the concrete member. These forms can be left in place for a prolonged period to prevent moisture loss, and can be wetted if made of a material suitable for wetting. If the forms are removed early, the concrete member is moistened and covered with polythene sheets to maintain moisture. For large horizontal concrete surfaces exposed to dry weather, a temporary covering is suspended...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...